Filing Details

Accession Number:
0000950170-24-124232
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-11-08 17:07:14
Reporting Period:
2024-11-07
Accepted Time:
2024-11-08 17:07:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1157601 Madrigal Pharmaceuticals Inc. MDGL Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1454983 S Richard Levy C/O Madrigal Pharmaceuticals, Inc.
200 Barr Harbor Drive, Suite 400
West Conshohocken PA 19428
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-11-07 5,000 $7.36 16,012 No 4 M Direct
Common Stock Disposition 2024-11-07 5,000 $350.00 11,012 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2024-11-07 5,000 $0.00 5,000 $7.36
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,000 2026-08-11 No 4 M Direct
Footnotes
  1. These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023.
  2. The shares underlying this option are fully vested and exercisable.